ASAli Semati

Ali Semati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Semati has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Efficacy of single‐dose and double‐dose ivermectin early treatment in preventing progression to hospitalization in mild COVID‐19: A multi‐arm, parallel‐group randomized, double‐blind, placebo‐controlled trial

    by Alireza Mirahmadizadeh, Ali Semati, Alireza Heiran, Mostafa Ebrahimi, Abdolrasool Hemmati, Mohammadreza Karimi, Souzan Basir, Marjan Zare, Antonio Charlys da Costa, Mohammad Zeinali, et al.

    Background and objective: Ivermectin is a known anti‐parasitic agent that has been investigated as an antiviral agent against coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of ivermectin in mild COVID‐19 patients.Methods: In this multi‐arm randomized clinical trial conducted between 9 April 2021 and 20 May 2021, a total of 393 patients with reverse transcription‐PCR‐confirmed COVID‐19 infection and mild symptoms were enrolled. Subjects were randomized in a 1:1:1 ratio to receive single‐dose ivermectin (12 mg), double‐dose ivermectin (24 mg) or placebo. The primary outcome was need for hospitalization.Results: There was no significant difference in the proportion of subjects who required hospitalization between the placebo and single‐dose ivermectin groups (absolute difference in the proportions: −2.3 [95% CI = −8.5, 4.1]) and between the placebo and double‐dose ivermectin groups (absolute difference in the proportions: −3.9 [95% CI = −9.8, 2.2]). The odds of differences in mean change in severity score between single‐dose ivermectin and placebo groups (ORdifference = 1.005 [95% CI: 0.972, 1.040]; p = 0.762) and double‐dose ivermectin and placebo groups (ORdifference = 1.010 [95% CI: 0.974, 1.046]; p = 0.598) were not statistically significant. None of the six adverse events (including mild dermatitis, tachycardia and hypertension) were serious and required extra action.Conclusion: Single‐dose and double‐dose ivermectin early treatment were not superior to the placebo in preventing progression to hospitalization and improving clinical course in mild COVID‐19.


  • Open Access

    Spatiotemporal Study of COVID-19 in Fars Province, Iran, October-November 2020: Establishment of Early Warning System

    by Ali Semati, Azimeh Zare, Marjan Zare, Alireza Mirahmadizadeh, Mostafa Ebrahimi

    Background. Using time series and spatiotemporal analyses, this study aimed to establish an Early Warning System (EWS) for COVID-19 in Fars province Iran. Methods. A EWS was conducted on (i) daily basis city-level time series data including 53 554 cases recorded during 18 February–30 September 2020, which were applied to forecast COVID-19 cases during 1 October–14 November 2020, and (ii) the spatiotemporal analysis, which was conducted on the forecasted cases to predict spatiotemporal outbreaks of COVID-19. Results. A total of 55 369 cases were forecasted during 1 October–14 November 2020, most of which (26.9%) occurred in Shiraz. In addition, 65.80% and 34.20% of the cases occurred in October and November, respectively. Four significant spatiotemporal outbreaks were predicted, with the Most Likely Cluster (MLC) occurring in ten cities during 2–22 October ( for all). Moreover, subgroup analysis demonstrated that Zarrindasht was the canon of the epidemic on 6 October ( ). As a part of EWS, the epidemic was triggered from Jahrom, involving the MLC districts in the center, west, and south parts of the province. Then, it showed a tendency to move towards Zarrindasht in the south and progress to Lar in the southernmost part. Afterwards, it simultaneously progressed to Fasa and Sepidan in the central and northwestern parts of the province, respectively. Conclusion. EWS, which was established based on the current protocol, alarmed policymakers and health managers on the progression of the epidemic and on where and when to implement medical facilities. These findings can be used to tailor province-level policies to servile the ongoing epidemic in the area; however, governmental level effort is needed to control the epidemic at a larger scale in the future.

  • Open Access

    Spatial epidemiology and meteorological risk factors of COVID-19 in Fars Province, Iran

    by Marjan Zare, Ali Semati, Alireza Mirahmadizadeh, Abdulrasool Hemmati, Mostafa Ebrahimi

    This study aimed at detecting space-time clusters of COVID-19 cases in Fars Province, Iran and at investigating their potential association with meteorological factors, such as temperature, precipitation and wind velocity. Time-series data including 53,554 infected people recorded in 26 cities from 18 February to 30 September 2020 together with 5876 meteorological records were subjected to the analysis. Applying a significance level of P<0.05, the analysis of space-time distribution of COVID-19 resulted in nine significant outbreaks within the study period. The most likely cluster occurred from 27 March to 13 July 2020 and contained 11% of the total cases with eight additional, secondary clusters. We found that the COVID-19 incidence rate was affected by high temperature (OR=1.64; 95% CI: 1.44-1.87), while precipitation and wind velocity had less effect (OR=0.84; 95% CI: 0.75-0.89 and OR=0.27; 95% CI: 0.14-0.51), respectively.


  • Open Access

    Pattern of Changes in Age-specific Fertility Rates, Total Fertility Rate, and Cohort Fertility Rate in Rural Areas of Fars Province, Southern Iran (1988-2012)

    by Haleh Ghaem, Marjan Zare, Abdulrasool Hemmati, Mohsen Moghadami, Fariba Moradi, Ali Semati

    Objective: To investigate the trend of changes in Age-Specific Fertility Rate (ASFR), Total Fertility Rate (TFR), and Cohort Fertility Rate (CFR) in rural areas of Fars province, southern Iran during 1988-2012. Materials and methods: This cross-sectional study was conducted based on analyze fluctuations in fertility. Information about the number of births and mothers aged 15-49 years was collected. By calculating the ASFR, TFR, and CFR along with analyzing their patterns the trend of changes in fertility rate would be revealed. Finally, modeling and time series forecast of ASFR based on age groups was conducted using the SPSS software. Results: The TFR was estimated to be 4.21, 2.1, 1.76, 1.65, and 1.78 per thousand in 1992, 1997, 2002, 2007, and 2012, respectively. Moreover, CFR was 2.01, 1.54, 1.05, 0.54, and 0.13 for those born during 1972-1976, 1977-1981, 1982-1986, 1987-1990, and 1991-1995, respectively. Also the time trend of ASFR based on age groups showed a negative slope. Conclusion: The fertility followed a negative slope during 1992-2012, indicating their descending trend during these years. TFR = 2.1 was a standard population replacement rate in the societies. Therefore, continual decline of this rate during 1992-2012 could be a warning factor that requires planning for reform and precise evaluation.